Prudent Man Advisors, LLC Neogenomics Inc Transaction History

Prudent Man Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$30.49 - $48.49 $196,325 - $312,227	-6,439 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $1,374 - $1,733	-33 Reduced 0.51%	6,439 $311,000
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $1,329 - $1,916	32 Added 0.5%	6,472 $312,000
Q4 2020 Feb 11, 2021	BUY	$36.08 - $56.47 $577 - $903	16 Added 0.25%	6,440 $347,000
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $88,471 - $107,676	-2,660 Reduced 29.28%	6,424 $237,000

Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $219,923 - $281,785	9,084 New	9,084 $281,000

282

128M

1.13M

232K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.71B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prudent Man Advisors, LLC with notifications on news.